 - Subjects must have been surgically or medically castrated. If method of castration is luteinizing hormone-releasing hormone LHRH agonist leuprolide or goserelin, then the Subject should be willing to continue the use of LHRH agonists. Castration using LHRH agonist should not be interrupted and subjects who have stopped treatment should be willing to restart. 